Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2366-1089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer ; volume:11 ; number:1 ; day:3 ; month:1 ; year:2023 ; pages:49-64 ; date:3.2023
Oncology and Therapy ; 11, Heft 1 (3.1.2023), 49-64, 3.2023
- Urheber
-
Chhaya, Saachi
Watts, Isabella
Ng, Kenrick
Mustapha, Rami
Powles, Thomas
Sharma, Anand
Vasdev, Nikhil
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40487-022-00218-z
- URN
-
urn:nbn:de:101:1-2023041921082240882223
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chhaya, Saachi
- Watts, Isabella
- Ng, Kenrick
- Mustapha, Rami
- Powles, Thomas
- Sharma, Anand
- Vasdev, Nikhil
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Protein interactome of muscle invasive bladder cancer
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Adaptive radiotherapy for muscle invasive bladder cancer: a retrospective audit of two bladder filling protocols
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Protein interactome of muscle invasive bladder cancer
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Adaptive radiotherapy for muscle invasive bladder cancer: a retrospective audit of two bladder filling protocols
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Protein interactome of muscle invasive bladder cancer
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Adaptive radiotherapy for muscle invasive bladder cancer: a retrospective audit of two bladder filling protocols
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer